La cadena de opciones muestra datos clave de las opciones de acciones de Eledon Pharmaceuticals a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Eledon Pharmaceuticals..

Eledon Pharmaceuticals (NASDAQ:ELDN) Bolsa, Cadena de Opciones

Eledon Pharma

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals Inc

Biotech

News

Health Care

General

BTAI

BioXcel Therapeutics Announced The Second Positive Recommendation By An Independent Data Safety Monitoring Board To Continue, Without Modification, SERENITY At-home Pivotal Phase 3 Safety Trial Of BXCL501 For Acute Treatment Of Agitation Associated With Bipolar Disorders Or Schizophrenia

<a href="https://www.globenewswire.com/Tracker?data=B7tw_SO0EIaKsJ8U2ptgerj7MQYCVzKu9NFy1vl5dbf25_WFwPTEk9FUz6pFUgrxvl9l8LMTwVdxsDfKbDsPBxe-e-QJ8GEz1U8K3jJGCbs=">Banzai International, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) ("Banzai" or the "Company"), a leading marketing technology company that provides essential marketing and sales solutions, today announced the completion of an $11.0 million dollar debt facility with an institutional investor to support acquisitions and ongoing operations.
The financing includes an initial tranche of $2.2 million (the "Note"), which matures on June 30, 2026, bears interest at 10% per annum, and is secured by the Company's assets. The principal amount of the Note is payable in cash or convertible in whole or in part into common shares at the holder's discretion at 115% of the price of the common stock immediately preceding the Closing Date. The company has the right to draw subsequent tranches, provided that certain conditions are met or waived.
Banzai intends to use the net proceeds from the facility for working capital, acquisitions, and general corporate purposes to support its future growth.

BNZI

Banzai Secures $11M Debt Deal to Fuel Acquisitions and Growth Plans

Management

KIRK

Kirkland's Appoints Andrea Courtois As SVP, CFO, Succeeding Mike Madden, Effective July 21, 2025

Steel Dynamics, Inc. (NASDAQ/GS: STLD) today announced each of the company's steel mills achieved Global Steel Climate Council (GSCC) product certification. The GSCC provides product certification, validating that these steel products are on the glidepath to achieve the goals of the Paris Climate Agreement's 1.5° C scenario.
&nbsp;
The GSCC's Steel Climate Standard provides a single, technology neutral framework for product certification allowing steel customers transparency when making lower-carbon emissions steel product purchasing decisions. The Steel Climate Standard is aligned with the International Energy Agency's Net Zero by 2050: A Roadmap for the Global Energy Sector. The Steel Climate Standard measures key steelmaking greenhouse gas (GHG) emissions through hot rolling including Scope 1, Scope 2, and upstream Scope 3 emissions categories. Each of the company's steel mills 2024 GHG emissions intensity data were verified by a third-party, KERAMIDA, and certified by the GSCC.

STLD

Steel Dynamics Earns Global Climate Certification for All Mills, Advancing Low-Carbon Steel Goals

HC Wainwright &amp; Co. analyst Joseph Pantginis assumes Travere Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) with a Buy rating and announces Price Target of $30.

Price Target

Initiation

Analyst Ratings

TVTX

HC Wainwright & Co. Assumes Travere Therapeutics at Buy, Announces Price Target of $30

Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>) today announced that it has entered into a definitive agreement to purchase the containerboard business of Greif, Inc. for $1.8 billion in cash. The transaction is expected to close by the end of PCA's third quarter, subject to certain customary conditions and regulatory approvals.
The Greif containerboard business includes two containerboard mills with approximately 800,000 tons of production capacity and eight sheet feeder and corrugated plants located across the United States. The business generated approximately $1.2 billion in sales and $212 million of earnings before interest, taxes, depreciation and amortization (EBITDA) for the 12 months ended April 30, 2025 (the LTM period).
Synergies are estimated to generate pre-tax benefits of approximately $60 million and are expected to be fully realized within two years after closing. The synergies are projected to come from improved operational and production capabilities and efficiencies at the mills, increased integration, mill grade optimization and lower transportation costs. Approximately one half of the benefits are expected by the end of the first year with the remainder being received by the end of the second year.
The purchase price represents a multiple of 8.5X LTM EBITDA and, with $60 million in benefits from synergies, the purchase price represents a multiple of 6.6X LTM EBITDA. The acquisition is expected to be accretive to earnings immediately.
PCA is expected to finance the transaction with $1.5 billion of new debt and cash on hand. PCA's pro forma leverage ratio (net debt to EBITDA) will be approximately 1.7X after completion of the transaction.

Packaging Corporation Of America Agrees To Purchase Containerboard Business Of Greif For $1.8B In Cash

The GEO Group, Inc. (NYSE:<a href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) ("GEO" or the "Company") announced today that it has entered into a purchase agreement with SDCC Middle Block, LLC (the "Seller"), an affiliate of Holland Partners Group, to acquire the 770-bed Western Region Detention Facility located in San Diego, California (the "San Diego Facility") for $60 million. GEO currently leases the San Diego Facility for approximately $5.1 million annually under a lease agreement that expires on March 31, 2029. GEO has a contract with the U.S. Marshals Service for the exclusive use of the San Diego Facility, which generates approximately $57 million in annualized revenues.
The purchase of the San Diego Facility is expected to close on July 31, 2025, subject to the satisfaction of customary closing conditions, and is expected to be funded as a like kind real estate property exchange with proceeds from the previously announced sale of the GEO-owned Lawton Correctional Facility in Oklahoma (the "Lawton Facility"), which is expected to close on July 25, 2025, resulting in an estimated capital gains cash tax savings of approximately $9.5 million.
Following the closing of the sale of the Lawton Facility and the purchase of the San Diego Facility, GEO expects to have approximately $222 million in net proceeds. GEO expects to use the net proceeds, along with cash on hand and available liquidity, to pay off senior secured debt, including approximately $300 million in floating rate debt, which is expected to position GEO to consider potential future capital returns.

GEO Group Enters Into Purchase Agreement With SDCC Middle Block To Acquire 770-Bed Western Region Detention Facility In San Diego, California For $60M

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates PDS Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDSB#NASDAQ">PDSB</a>) with a Buy and maintains $13 price target.

Reiteration

PDSB

HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $13 Price Target

The Education Department's loan servicer, MOHELA, is urging federal student-loan holders who filed for an income-driven repayment plan before April 27 to submit a new application, saying the do-over "may expedite processing."
What Happened: Spotted by Forbes <a href="https://www.forbes.com/sites/adamminsky/2025/06/30/student-loan-servicer-clarifies-who-should-reapply-for-an-idr-plan/">first</a>, the fresh guidance, posted on Monday after an earlier, muddled alert, adds that the original request will be canceled once the new form is filed. MOHELA recommends using the Internal Revenue Service data-retrieval tool on StudentAid.gov, restored in late March after a shutdown tied to litigation over the SAVE plan.
The system is straining under a backlog of nearly 2 million unprocessed IDR applications, <a href="https://protectborrowers.org/new-court-filing-reveals-backlog-of-2-million-borrower-payment-plan-applications/">says</a> the Student Borrower Protection Center (SBPC). Another <a href="https://tcf.org/content/commentary/the-assault-on-the-save-plan-has-brought-student-debt-relief-to-a-crossroads/">8 million</a> SAVE enrollees have been stuck in court-ordered forbearance since last summer, halting progress toward loan forgiveness. The 8th U.S. Circuit Court injunction also forced the department to pull the IDR form in February and <a href="https://studentloanborrowerassistance.org/idr-application-is-back-up/">reopen it</a> only partially on March 26.
MOHELA now says it has resumed processing for IBR, PAYE and ICR plans, but applications for SAVE or a "lowest payment" option remain frozen. Borrower advocates caution that the new filing offers no guarantee of speed and could trigger additional months of administrative forbearance that do not count toward forgiveness.
See also: <a href="https://www.benzinga.com/personal-finance/management/25/06/45917720/dont-wait-these-3-steps-could-save-you-a-ton-on-your-student-loans">Don&#8217;t Wait – These 3 Steps Could Save you a Ton on Your Student Loans</a>
No similar reapplication notice appears on the websites of other major servicers, and the department's own IDR-litigation page omits the advice.
Why It Matters: MOHELA's credibility has taken a hit over time. State investigations and a federal penalty last year <a href="https://www.aft.org/sites/default/files/media/documents/2024/AFT%20v.%20MOHELA_Complaint%2007.22.2024.pdf">alleged</a> the company misbilled millions of borrowers and posted interest during the SAVE freeze. Online forums remain flooded with <a href="https://www.reddit.com/r/StudentLoans/comments/1k1ueys/mohela_misreported_my_loans_during_save/">reports</a> of phantom interest and delinquency marks.
Single borrowers who can import verified IRS data may see the quickest results, reveal anecdotal evidence according to the Forbes report, while <a href="https://www.benzinga.com/personal-finance/25/04/44890297/married-borrowers-could-see-major-changes-to-student-loan-payments-whats-happening-with-idr-plans">married filers</a> often face longer waits. Until courts resolve the SAVE lawsuit, MOHELA says those accounts will stay in forbearance.
Read next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/personal-finance/financial-advisors/25/07/46188863/when-kevin-oleary-found-his-mother-was-secretly-an-investing-genius-the-performance-was-extraordinary-and-better-than-most-hedge-funds">When Kevin O&#8217;Leary Found His Mother Was Secretly An Investing Genius: &#8216;The Performance Was Extraordinary&#8217; And Better Than Most Hedge Funds</a></li>
</ul>
Image Via Shutterstock

Education

Personal Finance

Reapply Or Wait? Servicer MOHELA Says New IDR Applications May Move Faster — Here's What You Need To Know

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) with a Buy and maintains $720 price target.

ARGX

HC Wainwright & Co. Reiterates Buy on argenx, Maintains $720 Price Target

The U.S. Customs and Border Protection (CBP) has collected more than $106 billion in customs revenue since Donald Trump assumed the presidency, with a significant portion attributed to the administration&#8217;s tariffs.
What Happened:&nbsp;The Department of Homeland Security (DHS) announced on Monday that the CBP has amassed $106.1 billion in customs revenue since Trump&#8217;s inauguration. A significant portion of this revenue—$81.5 billion—was generated by tariffs imposed during the Trump Administration.
The CBP has achieved a success rate of over 99.5% in collecting customs duties and tariffs.&nbsp;The department has taken enforcement measures that led to recovering an additional $16.3 billion in revenue by targeting over 35,000 shipments identified as high-risk for duty evasion or requiring further payments.
A Senior DHS official stated, "We are proud to help President Trump make America richer and reverse a broken trade system that resulted in millions of jobs shipped overseas and made us dependent on foreign adversaries for essential goods.&#8221;
Meanwhile, Axios <a href="https://www.axios.com/2025/06/30/trump-tariffs-customs-revenue?ref=biztoc.com">reported </a>that from the start of the current fiscal year through the end of May, tariff collections are about 65% higher compared to the same period last year, according to Treasury data. Furthermore, the overall effective tariff rate has reached its highest point since the late 1930s, according to the Yale Budget Lab.
SEE ALSO: <a href="https://benzinga.com/markets/macro-economic-events/25/07/46187826/mike-pences-advocacy-group-launches-campaign-to-extend-trumps-2017-tax-cuts-report" target="_blank" rel="noreferrer noopener">Mike Pence&#8217;s Advocacy Group Launches Campaign To Extend Trump&#8217;s 2017 Tax Cuts: Report</a>
Why It Matters: The Trump administration&#8217;s trade policies have been a subject of global debate. The administration&#8217;s tariffs have been a significant source of revenue for the U.S. government. In April, U.S. customs revenue&nbsp;surged to an <a href="https://www.benzinga.com/markets/25/04/44979972/us-treasury-hits-record-15-billion-in-customs-and-excise-tax-haul-amid-trumps-trade-policies">all-time high</a>, delivering at least $15 billion in customs duties for the month — a more than 60% increase over previous periods.
However, the administration&#8217;s approach to trade has also sparked criticism. French President&nbsp;Emmanuel Macron&nbsp;recently&nbsp;criticized <a href="https://www.benzinga.com/news/politics/25/07/46186877/emmanuel-macron-calls-tariffs-blackmail-white-house-shoots-back-saying-trump-is-doing-whats-right-for-our-people">powerful nations</a>&nbsp;using tariffs as "blackmail" instruments, calling trade wars an "aberration."
Moreover, the Trump administration&#8217;s trade strategy has reportedly shifted, with the U.S. now&nbsp;<a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46188192/trump-administration-reportedly-scales-back-ambitions-for-comprehensive-trade-deals-before-tariff-deadline">favoring narrower agreements</a>&nbsp;to avoid the reimposition of U.S. tariffs. This change in strategy is a departure from the White House's initial plan to secure 90 trade deals during the 90-day pause in reciprocal tariffs announced by President Trump in April.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://www.benzinga.com/markets/macro-economic-events/25/06/46134994/eu-ready-for-a-deal-with-us-but-all-options-remain-on-the-table-says-von-der-leyen">EU &#8216;Ready For A Deal&#8217; With US But &#8216;All Options Remain On The Table&#8217;, Says Von Der Leyen</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tariffs Propel US Customs Revenue To A Record $106 Billion Since Trump's Inauguration

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">ChipMOS Technologies Inc &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMOS#NASDAQ">IMOS</a>)</h3>
<ul class="wp-block-list">
<li>On June 10, ChipMOS reported an 8.8% month-over-month increase in May revenue. The company's stock fell around 5% over the past five days and has a<a href="https://www.benzinga.com/quote/IMOS"> 52-week low of $12.7</a>8.</li>
<li>RSI Value: 29.4</li>
<li>IMOS Price Action: Shares of ChipMOS Technologies fell 2.2% to close at $18.11 on Monday.</li>
<li>Edge Stock Ratings: 21.57 Momentum score with Value at 98.62. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/imos"><img loading="lazy" decoding="async" width="432" height="181" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063726/image-5.png" alt="" class="wp-image-968395" style="width:325px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063726/image-5.png 432w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063726/image-5-300x126.png 300w" sizes="(max-width: 432px) 100vw, 432px" /></a></figure>
<h3 class="wp-block-heading">Clearone Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>)&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On June 30, ClearOne announced a special one-time stock dividend. The company's stock fell around 61% over the past six months and<a href="https://www.benzinga.com/quote/CLRO"> has a 52-week low</a> of $4.35.</li>
<li>RSI Value: 26.7</li>
<li>CLRO Price Action: Shares of Clearone gained 6.1% to close at $5.86 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in CLRO stock. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="923" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063835/image-6.png" alt="" class="wp-image-968397" style="width:611px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063835/image-6.png 923w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063835/image-6-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063835/image-6-768x701.png 768w" sizes="(max-width: 923px) 100vw, 923px" /></figure>
<h3 class="wp-block-heading">Foxo Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>)</h3>
<ul class="wp-block-list">
<li>On May 20, FOXO Technologies posted a first-quarter loss of 37 cents per share, versus a year-ago loss of 24 cents per share. The company's stock fell around 54% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/FOXO">low of $0.18</a>.</li>
<li>RSI Value: 28</li>
<li>FOXO Ltd Price Action: Shares of Foxo Technologies fell 2.6% to close at $0.18 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in FOXO shares.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="881" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063926/image-7.png" alt="" class="wp-image-968399" style="width:579px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063926/image-7.png 881w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063926/image-7-300x286.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01063926/image-7-768x733.png 768w" sizes="(max-width: 881px) 100vw, 881px" /></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46169288/5-stocks-in-the-spotlight-wall-streets-most-accurate-analysts-weigh-in">5 Stocks In The Spotlight: Wall Street&#8217;s Most Accurate Analysts Weigh In</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

CLRO

FOXO

IMOS

Top 3 Tech Stocks That Could Lead To Your Biggest Gains In July

CANG

Cango Produces 450 Bitcoins In June 2025; Completes Previously-Announced Acquisition To Boost Total Hashrate To 50 EH/s

Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) released its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/g46189067/li-auto-inc-june-2025-delivery-update" rel="noreferrer noopener">latest delivery numbers</a> on Tuesday, reporting 36,279 vehicles delivered in June 2025. This figure represents a 24.1% year-over-year decrease.
However, for the second quarter of 2025, the company saw a 2.4% year-over-year increase, delivering a total of 111,074 vehicles. As of June 30, 2025, Li Auto&#8217;s cumulative deliveries since its inception have reached 1,337,810.
In comparison, Li Auto delivered 47,774 vehicles <a target="_blank" href="https://www.benzinga.com/news/24/07/39574028/whats-going-on-with-chinese-ev-stocks-nio-li-auto-xpeng-on-monday" rel="noreferrer noopener">in June 2024</a>,&nbsp;up 46.7% year-over-year. This brought its second-quarter 2024 deliveries to 108,581, up 25.5% year-over-year.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/06/45902627/us-listed-chinese-tech-and-ev-stocks-slide-as-trump-confirms-china-trade-deal" rel="noreferrer noopener">US Listed Chinese Tech And EV Stocks Slide As Trump Confirms China Trade Deal</a>
Despite an earlier downward revision, Li Auto&#8217;s second-quarter delivery figures surpassed its <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/06/46136523/chinas-li-auto-cuts-outlook-as-xiaomi-challenges-ev-giants" rel="noreferrer noopener">adjusted guidance</a>. On June 27, the company had lowered its second quarter delivery forecast from 123,000-128,000 vehicles to about 108,000, explaining the change was due to temporary effects of sales system enhancements.
This adjustment to Li Auto&#8217;s projections coincided with the market entry of Xiaomi&#8217;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/XIACF#OTC">XIACF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/XIACY#OTC">XIACY</a>) budget-friendly YU7 SUV launch, which intensified pressure on rivals like Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) in the Chinese EV market.
The company said in a press release that the recently launched Li MEGA Home significantly exceeded sales expectations, making Li MEGA the top seller among MPVs priced above 500,000 Chinese yuan regardless of power source.
With the upcoming launches of the six-seat battery electric family SUV Li i8 in July, and the five-seat battery electric family SUV Li i6 in September, the company will establish a product lineup featuring four extended-range electric SUVs, one flagship MPV, and two high-voltage battery electric SUVs.
As of June 30, 2025, the company had 530 retail stores in 151 cities, 511 servicing centers, and Li Auto-authorized body and paint shops operating in 222 cities. It also had 2,851 supercharging stations in operation in China, equipped with 15,655 charging stalls.
Price Action: LI stock is trading lower by 0.18% to $27.06 premarket at&nbsp;last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/25/06/46174854/robinhood-just-made-crypto-simpler-and-way-more-powerful" target="_blank" rel="noreferrer noopener">Robinhood Just Made Crypto Simpler — And Way More Powerful</a></li>
</ul>
Photo by Robert Way via Shutterstock

Tech

TSLA

XIACF

XIACY

Li Auto's Strong Q2 Deliveries Mask June's Steep Decline

Thermon Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THR#NYSE">THR</a>) ("Thermon" or the "Company"), a global leader in industrial process heating solutions, today announced the promotion of Thomas Cerovski to Senior Vice President and Chief Operating Officer, effective as of July 1, 2025. Mr. Cerovski will continue to report to Thermon's Chief Executive Officer, Bruce Thames. In his expanded role, Mr. Cerovski will work with the leadership team to execute on the Company's key strategic pillars to drive the next level of growth and create value for shareholders. His priorities will include growing the installed base to capture recurring revenue and driving additional growth in Decarbonization, Digitization and Diversification while prudently deploying capital. All of this is underpinned by the Thermon Business System to form the value creation framework for the business. Mr. Cerovski has served as the Company's Senior Vice President, Global Business Units since 2019 and has managed the Company's profit and loss business units and commercial organization. "Tom has been an invaluable member of our executive team since joining Thermon six years ago, and we are looking forward to his continued contributions in this expanded leadership role," stated Bruce Thames, President and CEO of Thermon. "Tom is a proven leader and we believe that his extensive knowledge and experience across the industries and customers we serve, our product and service portfolio and the geographies in which we operate will be instrumental as we continue to execute on our long-term value creation framework."

Thermon Promotes Tom Cerovski to COO to Lead Growth and Strategy

Willy Woo, a widely followed Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) influencer and analyst, shared a controversial take Monday that called grouping altcoins and BTC under the "crypto" label a bad idea.
What happened: In an X post, Woo recalled a meeting with whom he claimed was the original creator of the Greed and Fear Index for TradFi.
"I asked him what he thought about BTC vs Alts. He nailed it&#8230; BTC is digital hard money. Alts are technology startups," Woo quoted the person as saying.
Woo, a Bitcoin maximalist, argued that BTC and altcoins are very different, and grouping them under the blanket term &#8220;crypto&#8221; is &#8220;dumbest.&#8221; 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Wrong. <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> maxis are using retarded logic to create separation&#8230; They are both founded with cryptography of which they are digital assets that utilize cryptographic techniques for security and verification Cryptography is the foundation of blockchain technology, enabling…
&mdash; Ξffex (@Sefex81) <a href="https://twitter.com/Sefex81/status/1939795522296193054?ref_src=twsrc%5Etfw">June 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
An X user, Ξffex, countered Woo's arguments, stating that both Bitcoin and altcoins are based on <a href="https://www.benzinga.com/money/what-is-cryptography">cryptography</a>, which serves as the "foundation of blockchain technology."
Another user, Aldo, argued for greater nuance, pointing out that several altcoins also differed significantly from one another.
They highlighted Litecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ltc/usd">LTC</a>)'s role in settling transactions, noting that it was far from being a technology startup.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">It's not black/white though. Litecoin is not the same as 99.99% of altcoins. Neither is Monero for that matter. Even when comparing market cap sizes (BTC &#8211; LTC, e.g.) Litecoin's usage in comparison is actually quite impressive.
&mdash; Aldo (@lite_hause) <a href="https://twitter.com/lite_hause/status/1939794845654200714?ref_src=twsrc%5Etfw">June 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46149584/why-crypto-investors-are-receiving-internal-revenue-service-warning-letters">Why Crypto Investors Are Receiving Internal Revenue Service Warning Letters</a>
Why It Matters: Woo is known for setting ambitious long-term price targets for Bitcoin. Earlier this month, he theorized that the apex cryptocurrency will be <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45740537/forget-dollars-willy-woo-says-bitcoin-will-be-priced-against-global-gdp-gold-used-to-be-that-money-btc-is-the-challenger">priced against global GDP</a> in the future.
According to CoinMarketCap, Bitcoin&#8217;s market dominance has <a href="https://coinmarketcap.com/charts/bitcoin-dominance/">risen </a>from 56% to 64.5% in the first half of 2025, while that of altcoins, excluding Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), has narrowed from 30.9% to 26.4%. When BTC dominance is high, it typically implies that investors are more confident in Bitcoin relative to other cryptocurrencies.
Price Action:&nbsp; At the time of writing, Bitcoin was exchanging hands at $106,588.13, down 0.85% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46148904/donald-trump-says-bitcoin-takes-a-lot-of-pressure-off-the-dollar">Donald Trump Says &#8216;Bitcoin Takes A Lot Of Pressure Off The Dollar&#8217;</a></li>
</ul>
Photo Courtesy: Bukhta Yurii On Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$LTC

Bitcoin Isn't Crypto? Analyst Willy Woo Slams Grouping BTC With Altcoins As 'Dumbest' Idea

Highway Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIHO#NASDAQ">HIHO</a>) reported quarterly losses of $(0.07) per share. This is a 73.08 percent increase over losses of $(0.26) per share from the same period last year. The company reported $1.487 million in sales this quarter. This is a 4.72 percent increase over sales of $1.420 million the same period last year.

Earnings

HIHO

Highway Holdings Q4 EPS $(0.07) Up From $(0.26) YoY, Sales $1.487M Up From $1.420M YoY

Tractors and Farm Equipment Limited ("TAFE"), one of the world's largest manufacturers of tractors and farm equipment, announced today that a comprehensive settlement and resolution has been reached withAGCO Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>) ("AGCO") on all matters relating to brand, commercial issues and shareholding.
The settlement encompasses the following key features:
<ul>
<li>Ownership of Massey Ferguson brand will rest with TAFE as the sole and exclusive owner for India, Nepal and Bhutan including all rights, title and interest in "Massey Ferguson" and related trademarks and all goodwill associated therewith.</li>
<li>TAFE will buy back AGCO's shares in TAFE which amounts to 20.7% of TAFE's equity for a consideration of $260 million thereby making TAFE a wholly owned subsidiary of the Amalgamations Group, a diversified industrial conglomerate, headquartered in Chennai, India.</li>
<li>TAFE will retainits shareholding in AGCO at an ownership level of 16.3%, and not exceed it, while participating in AGCO's future buyback programs to maintain its proportionate ownership subject to certain exceptions.</li>
<li>TAFE will support AGCO by voting of its shares in favor of all the recommendations of AGCO's Board of Directors at shareholder meetings, subject to certain exemptions.</li>
<li>TAFE will remain a long-term investor in AGCO through planned periodic interactions with AGCO leadership.</li>
<li>While all commercial agreements between TAFE and AGCO will be mutually terminated; TAFE will honour outstanding supply orders and continue to supply parts for all markets on agreed terms.</li>
<li>All ongoing legal proceedings will be irrevocably and unconditionally withdrawn. A consent decree will be sought in the three suits relating to Massey Ferguson brand-currently pending before the Madras High Court in India.</li>
</ul>
The agreements will become effective upon the completion by AGCO and TAFE of certain governmental and other processes in India relating to the repurchase of the shares held by AGCO in TAFE.

AGCO

TAFE Reaches Comprehensive Settlement And Resolution With AGCO On All Matters Relating To Brand, Commercial Issues And Shareholding

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="2" rowspan="1">Fourth Quarter Fiscal 2025 Financial Outlook</td>
</tr>
<tr>
<td colspan="1" rowspan="1">ADS Growth (YoY)</td>
<td colspan="1" rowspan="1">(0.5)% - 1.5%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted Operating Margin1</td>
<td colspan="1" rowspan="1">8.5% - 9.0%</td>
</tr>
<tr>
<td colspan="2" rowspan="1"> &nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Full-Year Fiscal 2025 Outlook for Certain Financial Metrics Maintained
<ul>
<li>Depreciation and amortization expense of ~$90M-$95M</li>
<li>Interest and other expense of ~$45M</li>
<li>Capital expenditures of ~$100M-$110M</li>
<li>Free cash flow conversion1 of ~120%</li>
<li>Tax rate of ~24.5%-25.0%</li>
</ul>
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">1 Guidance provided is a non-GAAP figure presented on an adjusted basis. For further details see the Non-GAAP financial measures information presented in the schedules accompanying this press release.</td>
</tr>
</tbody>
</table>
</figure>

Guidance

MSC Industrial Supply For Fourth Quarter Fiscal 2025 Projects ADS Growth Of (0.5)% To 1.5% And Adjusted Operating Margin Between 8.5% And 9.0%

Strategic Acquisition Expands AZZ's Metal Coatings Capabilities in the Midwest
FORT WORTH, Texas, July 1, 2025 /PRNewswire/ -- AZZ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>), the leading independent provider of hot-dip galvanizing and coil coating solutions in North America, today announced that it has entered into an agreement to acquire all the assets of Canton Galvanizing, LLC ("Canton"), a privately held hot-dip galvanizing company based in Canton, Ohio. Terms of the transaction were not disclosed. AZZ expects the acquisition will be accretive to earnings within the first year of operation. AZZ will operate the new facility under the name AZZ Galvanizing – Canton East LLC further extending AZZ's ability to support customers in the Midwest region of the United States. The new galvanizing facility will be integrated into AZZ's existing network of hot-dip galvanizing plants, increasing its total galvanizing network to 42 sites in North America.

AZZ To Acquire All Assets Of Canton Galvanizing; Terms Not Disclosed

Press Releases

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

ELDN

Alector

Anika Therapeutics

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Cabaletta Bio

Cellectis S.A. - American Depositary Shares

Cellectis

Cargo Therapeutics

Design Therapeutics

Editas Medicine

Eledon Pharmaceuticals

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Genfit

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

I-MAB

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Kodiak Sciences

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nuvectis Pharma

Puma Biotechnology

AVITA Medical

Spero Therapeutics

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

Voyager Therapeutics, Inc. - Common Stock

Comments

Eledon Pharmaceuticals

Eledon Pharmaceuticals (ELDN) Opciones

Eledon Pharmaceuticals (NASDAQ:ELDN) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL